ABC Arbitrage’s Apellis Pharmaceuticals APLS Stock Holding History

ABC Arbitrage’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-83,317	Closed	-$3.35M	–	391
2026 Q1	$3.35M	Buy	+83,317	New	+$1.8M	0.45%	54

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ABC Arbitrage's APLS Position: Q2 2026 in Review

ABC Arbitrage sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 83,317 shares — an estimated $3.35M sold.

ABC Arbitrage first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $3.35M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

ABC Arbitrage reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
ABC Arbitrage sold 83,317 Apellis Pharmaceuticals shares in Q2 2026, an estimated $3.35M.
ABC Arbitrage first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
ABC Arbitrage's Apellis Pharmaceuticals position peaked at $3.35M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on ABC Arbitrage's 13F filing for Q2 2026, filed 20 Jul 2026.